Mike Rogers | Chief Financial Officer |
Steve Hoffman | Chief Executive Officer |
Steve Pakola | Chief Medical Officer |
Kevin Peters | Chief Scientific Officer |
Jonathan Aschoff | National Securities |
Adnan Butt | Guggenheim |
Chad Messer | Needham & Company |
Yi Chen | H.C. Wainwright |
Good morning, ladies and gentlemen. Thank you for standing by and welcome to Aerpio Pharmaceuticals’ Third Quarter 2018 Financial Results and Business Update Conference Call.
As a reminder, this conference call may be recorded. It is now my pleasure to turn the call over to Mike Rogers, Aerpio's Chief Financial Officer. Please go ahead, sir.